| Gram-positive | Antibiotic resistance profile | CIP, | COT, | CLI, | E, | OXA, | FOX, | VA, | TE, | P, | C, | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) |
| S. aureus (38) | S | 36 (95) | 12 (32) | 27 (71) | 12 (31.5) | 9 (24) | 10 (26.3) | — | 9 (23.6) | 2 (5.2) | — | I | 1 (2.5) | 1 (2.6) | 0 (0) | 4 (10.5) | — | — | — | 2 (5.2) | — | — | R | 1 (2.5) | 25 (65) | 11 (29) | 22 (58) | 28 (73.6) | 28 (73.7) | — | 27 (71) | 36 (95) | — | CoNS (27) | S | 25 (92.5) | 11 (41) | 19 (70) | 10 (37) | 8 (30) | 9 (33.3) | — | 7 (26) | 2 (7.4) | — | I | 0 (0) | 2 (7.4) | 0 (0) | 3 (11) | — | — | — | 1 (3.7) | — | — | R | 2 (7.5) | 14 (52) | 8 (30) | 14 (52) | 19 (70) | 18 (66.7) | — | 19 (70.3) | 25 (93) | — | Enterococcus spp. (4) | S | 4 (100) | 2 (50) | — | 3 (75) | — | — | 4 (100) | 0 (0) | 0 (0) | 4 (100) | I | 0 (0) | 0 (0) | — | 0 (0) | — | — | 0 (0) | 1 (25) | 0 (0) | 0 (0) | R | 0 (0) | 2 (50) | — | 1 (25) | — | — | 0 (0) | 3 (75) | 4 (100) | 0 (0) | S. pneumoniae (8) | S | 7 (87.5) | 4 (50) | — | 5 (62.5) | — | — | 8 (100) | 2 (25) | 1 (12.5) | 5 (62.5) | I | 0 (0) | 0 (0) | — | 0 (0) | — | — | 0 (0) | 0 (0) | 0 (0) | 3 (37.5) | R | 1 (12.5) | 4 (50) | — | 3 (37.5) | — | — | 0 (0) | 6 (75) | 7 (87.5) | 0 (0) | Total (n = 77) | S | 72 (93.5) | 29 (37.6) | — | 30 (39) | — | — | 69 (90) | 18 (23.4) | 5 (6.5) | — | I | 1 (1.3) | 3 (3.9) | — | 7 (9) | — | — | 2 (2.6) | 4 (5.2) | 0 (0) | — | R | 4 (5.2) | 45 (58.4) | — | 40 (52) | — | — | 6 (7.7) | 55 (71.4) | 72 (95.5) | — |
|
|
Note. CIP, ciprofloxacin; COT, cotrimoxazole; E, erythromycin; P, penicillin; VA, vancomycin; OXA, oxacillin; CLI, clindamycin; FOX, cefoxitin; CN, gentamycin; TE, tetracycline; S, sensitivity, I, intermediate; R, resistance; CONS, coagulase-negative Staphylococci.
|